# Tolperisone in Acute Muscle Spasm of the Back

> **NCT03802565** · PHASE2 · COMPLETED · sponsor: **Neurana Pharmaceuticals, Inc.** · enrollment: 415 (actual)

## Conditions studied

- Back Pain
- Acute Pain
- Back Spasm Upper Back
- Back Strain
- Muscle Cramp
- Muscle Spasm
- Low Back Pain

## Interventions

- **DRUG:** Tolperisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03802565
- **Lead sponsor:** Neurana Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-07-12
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802565, "Tolperisone in Acute Muscle Spasm of the Back". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03802565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*